| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 07/13/2005 | EP1551495A2 Basic esters of fatty alcohols and their use as anti-inflammatory or immunomodulatory agents |
| 07/13/2005 | EP1551452A1 Compositions and methods for therapeutic treatment |
| 07/13/2005 | EP1551449A1 Reagents and methods for engaging unique clonotypic lymphocyte receptors |
| 07/13/2005 | EP1551444A2 Method for treatment of demyelinating central nervous system disease using gm-csf |
| 07/13/2005 | EP1551434A2 Identification of actinobacillus actinomycetemcomitans antigens for use in the diagnosis, treatment, and monitoring of periodontal diseases |
| 07/13/2005 | EP1551412A1 Pharmaceutical compositions for the treatment of diseases related to neurotrophines |
| 07/13/2005 | EP1551406A1 Use of indolyl derivatives for the manufacture of a medicament for the treatment of allergic rhinitis |
| 07/13/2005 | EP1551386A2 Methods and compositions for the treatment of lupus using clofarabine |
| 07/13/2005 | EP1551381A2 Styrylacrylonitrile compounds for inhibition of vascular endothelial growth factor |
| 07/13/2005 | EP1551375A1 Pharmaceutical formulation comprising cyclosporin, propylene glycol ester and non-ionic surfactant |
| 07/13/2005 | EP1551228A2 Synthetic c-glycolipid and its use for treating cancer infectious diseases and autoimmune diseases |
| 07/13/2005 | EP1551221A2 Nucleic acid compositions for stimulating immune responses |
| 07/13/2005 | EP1448529B1 Sulfone derivatives suitable for the treatment of autoimmune diseases and allergies |
| 07/13/2005 | EP1207860A4 Controlled release pellet formulation |
| 07/13/2005 | EP1202722B1 Uses of compositions for treating or preventing sleep disturbances using very low doses of cyclobenzaprine |
| 07/13/2005 | EP1161415B1 N-cyanomethylamides as protease inhibitors |
| 07/13/2005 | EP1042291B1 Aryl-substituted pyridylalkane, alkene, and alkine carboxamides useful as cytostatic and immunosuppressive agents |
| 07/13/2005 | CN1639569A Methods and compositions for inducing an immune response |
| 07/13/2005 | CN1639331A Methods and compositions for stable transgenic plant pharmaceuticals and their use as contraceptives |
| 07/13/2005 | CN1639322A Recombinant spores |
| 07/13/2005 | CN1639317A Probiotic lactobacillus salivarius strains |
| 07/13/2005 | CN1639190A Transmembrane NFAT inhibitory peptide |
| 07/13/2005 | CN1639188A Hepta-, octa- and nonapeptides having antiangiogenic activity |
| 07/13/2005 | CN1639161A Alkyne-aryl phosphodiesterase-4 inhibitors |
| 07/13/2005 | CN1639159A N-aminoacetyl-pyrrolidine-2-carbonitriles and their use as DDP-IV inhibitors |
| 07/13/2005 | CN1639154A Pyranones useful as ATM inhibitors |
| 07/13/2005 | CN1639153A Indolylmaleimide derivatives |
| 07/13/2005 | CN1639141A New thiadiazoles and oxadiazoles and their use as phosphodiesterase-7 inhibitors |
| 07/13/2005 | CN1639139A 5-phenylthiazole derivatives and use as PI3 kinase inhibitors |
| 07/13/2005 | CN1639132A N-pyrazinyl-phenylsulphonamides and their use in the treatment of chemokine mediated diseases |
| 07/13/2005 | CN1639126A Nitrosodiphenylamine derivatives and their pharmaceutical use against oxidative stress pathologies |
| 07/13/2005 | CN1639125A New inhibitors of histone deacetylase |
| 07/13/2005 | CN1639119A Substituted 2-amino-cycloalkanecarboxamides and their use as cysteine protease inhibitors |
| 07/13/2005 | CN1638823A N-{5-[4-(4-methyl-piperazino-methyl)--benzoylamido]-2-methylphenyl}-4-(3-pyridyl)-2-pyrimidine-amine coated stents |
| 07/13/2005 | CN1638808A Coupling proteins to a modified polysaccharide |
| 07/13/2005 | CN1638800A Human monoclonal antibodies against CD30 |
| 07/13/2005 | CN1638799A Human mast cell-expressed membrane proteins |
| 07/13/2005 | CN1638796A Methods of administering anti-TNF alpha antibodies |
| 07/13/2005 | CN1638786A Improvements in or relating to immune functions |
| 07/13/2005 | CN1638780A Methods for particle-assisted polynucleotide immunization using a pulsed electric field |
| 07/13/2005 | CN1638776A Substituted 3-aryl-5-aryl-[1, 2, 4]-oxadiazoles and analogs |
| 07/13/2005 | CN1638762A Azabicyclic, azatricyclic and azaspirocyclic derivatives of aminocyclohexane NMDA, 5HT3, and neuronal nicotinic receptor antagonists |
| 07/13/2005 | CN1638760A Treatment of pain, inflammation, and inflammation-related disorders with a combination of a cyclooxygenase-2 selective inhibitor and aspirin |
| 07/13/2005 | CN1638747A Sustained release pharmaceutical composition |
| 07/13/2005 | CN1638734A Drug delivery system for the subconjunctival administration of fine grains |
| 07/13/2005 | CN1638650A Composition improving age-related physiological deficits and increasing longevity |
| 07/13/2005 | CN1637020A Polyol-ifn-beta conjugates |
| 07/13/2005 | CN1637009A Extraction process of total rehmannioside |
| 07/13/2005 | CN1636994A Process of preparing alkali metal salys of hydrophobic sulfonamides and alkali metal salt produced thereby |
| 07/13/2005 | CN1636983A Substituted heterocyclic compounds |
| 07/13/2005 | CN1636980A 二肽腈组织蛋白酶k抑制剂 Dipeptide nitrile cathepsin inhibitors k |
| 07/13/2005 | CN1636592A Stabilized liquid polypeptide-containing pharmaceutical composition |
| 07/13/2005 | CN1636567A Piperazine derivative used as CCRS antagonist |
| 07/13/2005 | CN1636554A Process for producing soft gelatin capsule |
| 07/13/2005 | CN1210401C Compound from moraxella catarrhalis |
| 07/13/2005 | CN1210279C Thiazolo (4,5-D) pyrimidine compounds |
| 07/13/2005 | CN1210273C Substituted 3-pyridyl-4-arylpyrroles, and related therapeutic and prophylactic methods |
| 07/13/2005 | CN1210270C Novel use of phenylheteroalkylamine derivatives |
| 07/13/2005 | CN1210263C N-hydroxy-2-(alkyl, aryl or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors |
| 07/13/2005 | CN1210251C Substituted nor bornylamion derivatives, method for production thereof, use thereof and medicaments containing said compounds |
| 07/13/2005 | CN1210250C Benzene derivatives, preparation method and pharmaceutical compositions containing same |
| 07/13/2005 | CN1210065C Solid dispersion system with Pranlukast for improving dissolution, and the preparing method thereof |
| 07/13/2005 | CN1210062C Pig erysipelothrix rhusiopathiae antigen and vaccine composition thereof |
| 07/13/2005 | CN1210053C Immunologic function excitant for treating AIDS |
| 07/13/2005 | CN1210033C Immunodepressive medicine and its preparing process and application |
| 07/13/2005 | CN1210026C Melatonin two-layer release-controlled tablet and preparing process thereof |
| 07/13/2005 | CN1210019C II type collagen water soluble dispersion composition, its preparation method and application |
| 07/12/2005 | US6916927 Pyrazolopyrimidinones which inhibit type 5 cyclic guanosine 3′,5′-monophosphate phosphodiesterase (cGMP-PDE5) for the treatment of sexual dysfunction |
| 07/12/2005 | US6916838 1-benzylpyrazole-3-carboxylic acid tricyclic derivatives as cannabinoid receptor antagonists |
| 07/12/2005 | US6916834 Preparations and use of an Ah receptor ligand, 2-(1′H-indole-3′-carbonyl)-thiazole-4-carboxylic acid methyl ester |
| 07/12/2005 | US6916815 C-6 modified indazolylpyrrolotriazines |
| 07/12/2005 | US6916809 Heterocyclic acridone inhibitors of IMPDH enzyme |
| 07/12/2005 | US6916807 Triaryl-oxy-aryl-spiro-pyrimidine-2,4,6-trione metalloproteinase inhibitors |
| 07/12/2005 | US6916804 Pyrimidine A2b selective antagonist compounds, their synthesis and use |
| 07/12/2005 | US6916797 α-arylethylpiperazine derivatives as neurokinin antagonists |
| 07/12/2005 | US6916785 Homogeneous cyclosporin-containing solution |
| 07/12/2005 | CA2452172A1 Methods and compositions for modulating cell activation and uses thereof |
| 07/12/2005 | CA2323008C Pharmaceutically active compounds |
| 07/12/2005 | CA2105867C Novel imidazole derivatives, their preparation and therapeutic applications |
| 07/12/2005 | CA1341485C Fusion proteins utilizing the decay accelerating factor membrane binding domain |
| 07/07/2005 | WO2005060992A1 Therapeutic agents and uses therefor |
| 07/07/2005 | WO2005037839A8 Norcantharidin derivative compounds, method for the production thereof, compositions containing said compounds and the use thereof |
| 07/07/2005 | WO2004100868A3 Method of treating transplant rejection |
| 07/07/2005 | WO2003089583A3 Tissue specific genes and gene clusters |
| 07/07/2005 | US20050148672 reacting methyl bromide and 2-[(1R)-3-(diisopropylamino)-1-phenylpropyl]-4-(trifluoromethyl) phenol; formation of (3R)-3-[2-hydroxy-5-(trifluoromethyl)phenyl]-N,N-diisopropyl-N-methyl-3-phenylpropan-1-aminium bromide; asthma, chronic obstructive pulmonary disorder, allergic and infectious rhinitis |
| 07/07/2005 | US20050148664 therapy of NF-kappaB mediated diseases; mitochondrial diseases; transplantation medicine |
| 07/07/2005 | US20050148644 Ligands for Inosine-5'-monophosphate dehydrogenase; antiviral, antiinflammatory, antibiotics, transplant rejection, autoimmune disease, , antipsoriatic immunosuppressants; 3-uriedo benzyl carbamate derivatives; high potency, side effects reduction; bioavailability; antivascular hyperproliferative |
| 07/07/2005 | US20050148637 Neurotrophic low molecular weight ketones and tioester compounds for treatment of nervous system disorders and neurodegenerative conditions |
| 07/07/2005 | US20050148625 Use of estrogen antagonists and estrogen agonists inhibiting pathological conditions |
| 07/07/2005 | US20050148620 Administering N-(2-{2-[4-amino-2-(2-methoxyethyl)-1H-imidazo[4,5-c]quinolin-1-yl]ethoxy}ethyl)methanesulfonamide as immune response modifier for treating viral and neoplastic diseases |
| 07/07/2005 | US20050148619 Sulfonamido ether substituted imidazoquinolines |
| 07/07/2005 | US20050148608 Chymase enzyme inhibitors for drugs in vascular systems using sulfonylurea derivatives |
| 07/07/2005 | US20050148604 Increase the intracellular cAMP level and further inhibit the activation of T cells; allergic diseases, inflammatory or immunological diseases |
| 07/07/2005 | US20050148588 LFA-1 antagonist compounds |
| 07/07/2005 | US20050148580 Non-opioid analgesics for chronic and acute pain; 1-[1-(p-phenylbenzyl)-4-piperidinyl]-2,1,3-benzothiadiazol-2,2-dione; modulation of the opioid and ORL I receptors; agonist or antagonist activity at the CNS mu, delta and kappa receptors greater than morphine |
| 07/07/2005 | US20050148575 (Di)Azepino[5,4,3-cd]benzothiophenes; poly(ADP-ribose) polymerase (PARP) and glycohydrolase (PARG) inhibitor; antiinflammatory; protects cells, tissue and organs against the ill-effects of reactive free radicals and nitric oxide, and damage following focal ischemia and reperfusion injury |
| 07/07/2005 | US20050148537 Immunostimulatory nucleic acid molecules |
| 07/07/2005 | US20050148062 Transgenic microorganisms comprising apoptosis associated genes for use as tools in identifying modulators for prevention and treatment of cell proliferative disorders |
| 07/07/2005 | US20050148014 Regulation of human P2Y1-like G protein-coupled receptor |
| 07/07/2005 | US20050147971 Biomolecule transduction motif mph-1-btm and the use thereof |